Showing results (301-310 of 2,504) with videos related to

Sort By:
Pageof 251
Endocrine-Related Cancer|September 13, 2017
Immunotherapy against endocrine malignancies: immune checkpoint inhibitors lead the wayLucas Leite Cunha, Marjory Alana Marcello, Vinicius Rocha-Santos, et al.
Endocrine-Related Cancer|September 14, 2017
The future: genetics advances in MEN1 therapeutic approaches and management strategiesSunita K Agarwal
Endocrine-Related Cancer|February 21, 2018
Attenuation of NK cells facilitates mammary tumor growth in streptozotocin-induced diabetes in miceNevena Gajovic, Milena Jurisevic, Jelena Pantic, et al.
Endocrine-Related Cancer|February 15, 2018
Non-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancersCarolyn M Klinge
Endocrine-Related Cancer|February 16, 2018
The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell linesTobias Hofving, Yvonne Arvidsson, Bilal Almobarak, et al.
Endocrine-Related Cancer|February 18, 2018
Role of biomarkers in predicting the occurrence of thyroid neoplasms in radiation-exposed childrenJoseph M Shulan, Leonid Vydro, Arthur B Schneider, et al.
Endocrine-Related Cancer|February 2, 2018
Modifying impact of RET gene haplotypes on medullary thyroid carcinoma clinical courseMarta Kaczmarek-Ryś, Katarzyna Ziemnicka, Andrzej Pławski, et al.
Endocrine-Related Cancer|January 11, 2018
IAPs cause resistance to TRAIL-dependent apoptosis in follicular thyroid cancerThomas A Werner, Inga Nolten, Levent Dizdar, et al.
Endocrine-Related Cancer|January 4, 2018
Runx2 overexpression compromises bone quality in acromegalic patientsMaria Teresa Valenti, Monica Mottes, Samuele Cheri, et al.
Endocrine-Related Cancer|January 14, 2018
Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trialMarianne Pavel, David J Gross, Marta Benavent, et al.
Pageof 251